Skip to main content

Balchem Corporation Value Stock - Dividend - Research Selection

Balchem corporation

ISIN: US0576652004 , WKN: 905650

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Dividend Champion, Contender, And Challenger Highlights: Week Of December 21

2025-12-19
Get the latest weekly summary on dividend changes, ex-dividend dates, and pay dates for Dividend Champions, Contenders, and Challengers.

Pfizer, Mastercard Among 24 Companies To Announce Annual Increases In December

2025-11-29
Most of the dividend increases announced in the last two weeks of November were in the low-to-mid single-digit percentages. Check out the upcoming dividend increases.

Balchem Corporation's (NASDAQ:BCPC) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

2025-11-14
Balchem's (NASDAQ:BCPC) stock is up by a considerable 10% over the past month. Since the market usually pay for a...

Balchem Corporation to Present at Baird’s 55th Annual Global Industrial Conference on November 12, 2025

2025-10-30
MONTVALE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at Baird’s 55th Annual Global Industrial Conference on November 12, 2025. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations, will present at the conference. About Balchem Corporation

Balchem: Bullish On Q3 Outperformance And Favorable Outlook (Upgrade)

2025-10-23
Balchem stock is upgraded to "Buy" as strong Q3 results and emerging food trends signal growth. Here's what investors need to know about BCPC stock.

Balchem (BCPC) Is Up 9.3% After Record Sales and Major Expansion Plans—What’s Changed?

2025-10-22
Balchem Corporation reported record third-quarter sales of US$267.56 million and net income of US$40.29 million, with year-over-year growth across all business segments, and announced plans to double its microencapsulation manufacturing capacity by early 2027. This milestone reflects both the company’s ability to offset headwinds like tariffs and its ongoing investments in innovative nutrient delivery technologies, positioning it to support continued high-margin sales expansion. We're going...

Balchem (BCPC): Evaluating Valuation After Record Q3 Results and Expansion Plans

2025-10-22
Balchem (BCPC) just reported record third-quarter sales and profit, highlighting year-over-year growth in all segments. The company also unveiled plans to expand manufacturing capacity, signaling continued investment in its future growth. See our latest analysis for Balchem. After a modest start to the year, investor sentiment has clearly picked up, with Balchem’s latest results helping drive a 10% gain in the share price over the past week alone. While the one-year total shareholder return...

Balchem Corp (BCPC) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ...

2025-10-21
Balchem Corp (BCPC) reports a robust quarter with record revenue and continued expansion across key segments, while addressing market challenges and capacity constraints.

Balchem (BCPC) Q3 2025 Earnings Call Transcript

2025-10-21
2025 was the twenty-fifth consecutive quarter of quarterly year-over-year growth in adjusted EBITDA for Balchem. Before we get into more detail on the quarter, I would like to make a few comments about the overall market environment, including the evolving global trade situation, as well as some of the new science that has recently been published supporting our nutrients and the further expansion of our marketing efforts to help drive awareness and market penetration.

Why Balchem Stock Jumped Today

2025-10-21
This behind-the-scenes nutrition company is capitalizing on "better for you" trends.